Nutritional Impact of Orkambi Treatment in 2 to 5 Year Old Children Homozygous for F508del Mutations
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2019
Price : $35 *
At a glance
- Drugs Ivacaftor/lumacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 10 Jun 2019 Planned primary completion date changed from 1 May 2019 to 1 May 2020.
- 11 Mar 2019 Planned initiation date(estimated date for recruitment of the first subject) changed to 1 Apr 2019.
- 04 Jan 2019 Status changed from planning to recruiting.